Please login to the form below

Not currently logged in
Email:
Password:

Michael Zaiac moves from GSK to Celgene

He takes up the role of VP, medical affairs, haematology-oncology EMEA

Celgene Michael ZaiacCelgene has appointed Michael Zaiac as vice president, medical affairs for its EMEA haematology-oncology business.

Zaiac joins the company's Switzerland-based international business from GlaxoSmithKline, where he was most recently franchise medical head for its immuno-inflammation and infectious diseases operations.

Prior to joining the pharmaceutical industry Zaiac served for several years as senior house officer in the UK in general, orthopaedic and cardiothoracic surgery, as well as working in Germany in general and vascular surgery and surgical oncology.

Marie-France Tschudin, corporate vice president of haematology-oncology at Celgene International, said “I am really pleased to have Michael on board to head up our haematology-oncology medical affairs team.

“This is a really exciting time for Celgene in EMEA, with three European approvals already in 2015, two of which are in haematology-oncology. His expertise in this area will give us the strong support we need at this fast-moving time.”

13th May 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

blood
‘How is your day?’
The initiative that shows how plasma protein therapies improve lives...
women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....

Infographics